Mark Collingbourne

Mark Collingbourne has a diverse work experience spanning over several companies and industries. Mark is currently working as the Chief Financial Officer at Probiotix Health PLC, where they are responsible for developing probiotics for cardiovascular and lifestyle conditions. Prior to this, they held the same role at Cytomos, a biotechnology company specializing in label-free analytics. Mark also served as the Chief Financial Officer at Intuitive Investments Group PLC, where they focused on investing in life sciences businesses. Before that, they were the Chief Finance Officer at OptiBiotix Health PLC, where they developed products to modify the human microbiome. Mark has also worked as the Managing Director at Morrison Kingsley Consultants and the Group Finance Director at ELM Group. Additionally, they have held various financial positions at Artemis Management Services Limited and Sosandar PLC. Mark was also a Non-Executive Director at Sosandar and the Chief Financial Officer at Novel Technologies Holdings Limited. Overall, Mark Collingbourne's work experience demonstrates their expertise in finance and their involvement in the life sciences and biotechnology sectors.

Mark Collingbourne attended Kelso High School from 1977 to 1983. Mark then enrolled at the University of Stirling from 1983 to 1987, where they obtained a Bachelor of Arts (B.A.) degree in Accounting. Mark Collingbourne also has a certification from the Association of Chartered Certified Accountants (FCCA), although the specific date of obtaining this certification is not provided.